L Koshy, R Vb, MP Ben, P Kishor… - …, 2022 - Taylor & Francis
Background: Vitamin K antagonists (VKAs) are class I oral anticoagulants that are widely prescribed following surgical heart valve implantation. The objective of this study was to …
TA Helin, L Joutsi‐Korhonen… - British Journal of …, 2019 - Wiley Online Library
Aims Warfarin dose requirement varies significantly. We compared the clinically established doses based on international normalized ratio (INR) among patients with severe thrombosis …
The aim of the study: to establish the frequencies of polymorphisms in VKORC1, CYP2C9 and CYP4F2 genes among residents of the Zaporizhzhia region. Materials and methods. A …
Để hoàn thành luận án này, trước hết, tôi xin bày tỏ lòng tri ân sâu sắc tới GS. TS. Tạ Thành Văn, Chủ tịch Hội đồng Trường, Nguyên Hiệu trưởng, Trưởng Bộ môn Hóa sinh Trường Đại …
DK Kumar, CRS Uppugunduri… - Current Drug …, 2021 - ingentaconnect.com
Background: Warfarin is primarily metabolized by cytochrome P450 2C9 (CYP2C9) enzyme, which is encoded by the CYP2C9 gene. CYP2C9* 2 and CYP2C9* 3 variants significantly …
Дисертація присвячена прогнозуванню безпечності та оптимізації антикоагулянтної терапії при фібриляції передсердь (ФП) шляхом дослідження клінічних особливостей …
S Zahedifar, S Ghadami, M Eslami… - … Science Journal of …, 2023 - tmuj.iautmu.ac.ir
Background: Warfarin is the most commonly prescribed anticoagulant drug for treating thromboembolic events. There is a variation in dose requirements for each individual due to …
W Peng, X Shi, Y Zhang, Y Zhang, J Han, J Yan… - 2022 - researchsquare.com
Background: To evaluate the accuracy and predictive performance of multiple linear regression algorithms, Gage algorithm and International Warfarin Pharmacogenetics …